A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

NCT03217591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Interventions

DRUG: IW-1973
DRUG: IW-1973
DRUG: Placebo

Sponsor

Akebia Therapeutics

Collaborators

[object Object]